cannabis investment
cannabis investment · page 3
- Uncategorized
Business of Cannabis: New York 2025 – Policy, Investment and Market Growth
At a Glance Date: Thursday, 6 November 2025 Venue: The Wythe Hotel, Williamsburg, New York Attendees: 200+ industry leaders, investors, and policymakers Focus: Regulation, retail strategy, investment, and market growth Tickets: [Purchase here] Where New York’s Cannabis Industry Connects Business of Cannabis: New York returns to The Wythe Hotel on 6 November 2025, bringing together…
- Uncategorized
PTMC Lisbon 2025: Portugal’s Cannabis Industry at a Significant Inflection Point
On 25 September, PTMC hosted its seventh edition in central Lisbon, amid a growing sense that Portugal’s medical cannabis sector has reached an inflection point.
- Industry Trends
Manufactured Optimism: Why Trump Can’t ‘Just Wave a Magic Wand’ and Reschedule Cannabis
There is a frustrating misimpression circulating in the cannabis community regarding rescheduling.
- Events
Cannabis Europa 2025 – Key Insights Day 2
Below, we’ve summarised the key insights from the vibrant and diverse discussions throughout Day 2 of Cannabis Europa 2025. If you’re keen to dive into the details, we’ll be exploring each session in more detail over the coming weeks.
- Companies
GROW to raise capital to scale UK operations and activities in Germany
The UK-based medicinal cannabis company is targeting a major expansion.
- Companies
Sanity Group closes Europe’s largest cannabis investment round
The Series B funding round closed at USD$37.6m (~£34.84m).
- Companies
Spanish Court opens case into JuicyFields alleged fraud scheme
The case has been opened following the filing of a collective lawsuit against the company in Spain in July.
- CBD Market
Swiss CBD investment company secures £26.23m funding
Pharma Tech Holding has obtained a capital commitment agreement from LDA Capital.
- Adult-Use
MGC Pharma receives first tranche of funding under new $10m financing facility
The financing facility will fund the execution of MGC Pharma’s business commercialisation strategy in the UK and US.
- Opinion
Opinion: former Juicy Fields CEO shares his thoughts on the case
“I might be off the mark, but I don’t think this was an intended Ponzi Scheme,” Willem van der Merwe.
- News
Tilray closes $155m investment in Canadian cannabis producer HEXO
“This partnership with Tilray Brands is a game-changer for HEXO,” said Charlie Bowman, CEO of HEXO Corp.
- Adult-Use
Cannaray: “We aim to become the leading medical cannabis player in Europe”
Cannaray recently closed a £10 million funding round to expand its medical cannabis arm.
